The approved 2 mg/week dose of semaglutide remains the upper limit recommended for balancing efficacy and safety for the treatment of type 2 diabetes
Sermorelin: usually once daily as a subcutaneous injection, with timing tailored to your plan
Tirzepatide may cause side effects such as nausea, vomiting, diarrhea, constipation, fatigue, decreased appetite, and stomach discomfort
Caffeine may make you feel more alert, but it does not reduce the alcohol level in your body - so you remain impaired
The medication reduces the risk of cardiovascular diseases such as stroke, myocardial infarction, hypertension, and heart failure, and ensures the kidneys get a steady and healthy blood supply